Discover 1,565 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,565
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: Newark NJ, Livingston NJ, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06524544
Phase3, Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Newark NJ, The Bronx NY, New Brunswick NJ, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05172245
Phase1, Recruiting
Cerebral Palsy Upper Extremity Orthotic Device
for
Cerebral Palsy
Location: Newark NJ, Union NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 4 - 17
Code: NCT05024409
Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Newark NJ, New York NY, New Haven CT, Albany NY,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Evaluation of the FELLAS Responsible Fatherhood Project
for
Responsible Fatherhood
Location: Newark NJ
Sponsor: Partnership for Maternal & Child Health of Northern New Jersey
Sex: Male
Age: 18+
Code: NCT05412641
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
for
Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8,
Location: Newark NJ, Livingston NJ, New Brunswick NJ,
Sponsor: Howard S. Hochster, MD
Sex: All
Age: 18+
Code: NCT05296681
Phase2, Recruiting
Effectiveness of Virtual Reality Vision Therapy - VERVE
for
Convergence Insufficiency
Location: Newark NJ
Sponsor: OculoMotor Technologies
Sex: All
Age: 9 - 35
Code: NCT04691427
Early_phase1, Recruiting
Menopausal HT for Women Living With HIV (HoT)
for
HIV Infection, Menopause
Location: Newark NJ, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
for
HIV Infections
Location: Newark NJ, Manhasset NY, Hackensack NJ, New Haven CT,
Sponsor: ViiV Healthcare
Sex: All
Age: 18+
Code: NCT07202546
Phase2, Recruiting
Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis
for
Infertility, Recurrent Pregnancy Loss
Location: Livingston NJ
Sponsor: Reprogenetics
Sex: Female
Age: 18 - 42
Code: NCT01946945
Phase2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Newark NJ, Jersey City NJ, New York NY, Summit NJ,
Location: Jersey City NJ, Marlton NJ, Detroit MI, Louisville KY,
Sponsor: ECRI bv
Sex: All
Age: 18+
Code: NCT06625801
Recruiting
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Newark NJ, New York NY, Bronx NY, Philadelphia PA,
Sponsor: Biomed Industries, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04452565
Phase2, Phase3, Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Union City NJ, The Bronx NY, Hamden CT, Glen Burnie MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase2, Recruiting
Non-Invasive Preeclampsia Screening and Biobank
for
Preeclampsia (PE)
Location: Livingston NJ, New York NY, New Brunswick NJ,
Sponsor: Sequenom, Inc.
Sex: Female
Age: 18+
Code: NCT06643741
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Livingston NJ, New York NY, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04172532
Phase1, Phase2, Recruiting
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
for
Hormone Receptor-Positive Breast Cancer,
Location: Livingston NJ, Newark NJ, Elizabeth NJ,
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT06518837
Phase2, Recruiting
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
for
Neoplasm Metastases, Metastases, Neoplasm
Location: Livingston NJ, New Brunswick NJ, Somerset NJ,
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05419518
Phase2, Recruiting
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: Livingston NJ, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05296421
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Livingston NJ, New Brunswick NJ, Long Branch NJ,